trial · primary record
AADvac1
Preclinical Alzheimer's Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 450 |
| Primary completion | 2028-08-31 |
| Primary endpoint | Reduction of brain tau deposition as measured by tau positron emission tomography (PET) |
| Registry ID | NCT07167966 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:32.936Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07167966
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.